ckd and semaglutide → 16% reduction in primary kidney composite (HR 0.84) 20% reduction in kidney-specific composite (HR 0.80), consistent across obesity, T2D, and populations — oral and injectable forms alike Ozempic-Induced Blindness? A Measured type_GLP-1 Tamaño:60 mg

ckd and semaglutide → 16% reduction in primary kidney composite (HR 0.84) 20% reduction in kidney-specific composite (HR 0.80), consistent across obesity, T2D, and populations — oral and injectable forms alike Ozempic-Induced Blindness? A Measured type_GLP-1 Tamaño:60 mg

Ozempic-Induced Blindness? A Measured Response | Office for Science and Society - McGill University

Because the medication works by the same mechanism—slowing gastric emptying and affecting brain signaling—the gastrointestinal responses remain the primary side effects regardless of the manufacturer

type_GLP-1

Tamaño:60 mg

Manufacturer support programs